Protein microarrays for genome-wide posttranslational modification analysis

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 3, Issue 3, 2011, Pages 347-356

  Merbl, Yifat ^a   Kirschner, Marc W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; GENETIC ASSOCIATION; HUMAN; METHODOLOGY; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEOMICS;

ANIMALS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS;

MAMMALIA;

EID: 79960319150     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.120     Document Type: Article

References (75)

1. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000, 289:1760-1763.
2. Angenendt P, Glokler J, Murphy D, Lehrach H, Cahill DJ. Toward optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem 2002, 309:253-260.
3. Feinberg JG. A 'microspot' test for antigens and antibodies. Nature 1961, 192:985-986.
4. Kusnezow W, Jacob A, Walijew A, Diehl F, Hoheisel JD. Antibody microarrays: an evaluation of production parameters. Proteomics 2003, 3:254-264.
5. Joos TO, Schrenk M, Hopfl P, Kroger K, Chowdhury U, Stoll D, Schorner D, Durr M, Herick K, Rupp S, et al. A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 2000, 21:2641-2650.
6. Walter JG, Kokpinar O, Friehs K, Stahl F, Scheper T. Systematic investigation of optimal aptamer immobilization for protein-microarray applications. Anal Chem 2008, 80:7372-7378.
7. Quintana FJ, Merbl Y, Sahar E, Domany E, Cohen IR. Antigen-chip technology for accessing global information about the state of the body. Lupus 2006, 15:428-430.
8. Quintana FJ, Hagedorn PH, Elizur G, Merbl Y, Domany E, Cohen IR. Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci U S A 2004, 101(suppl 2):14615-14621.
9. Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest 2007, 117:712-718.
10. Ge H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions. Nucleic Acids Res 2000, 28:e3.
11. Wolf-Yadlin A, Sevecka M, MacBeath G. Dissecting protein function and signaling using protein microarrays. Curr Opin Chem Biol 2009, 13:398-405.
12. Knickerbocker T, Chen JR, Thadhani R, MacBeath G. An integrated approach to prognosis using protein microarrays and nonparametric methods. Mol Syst Biol 2007, 3:123.
13. Sartain MJ, Slayden RA, Singh KK, Laal S, Belisle JT. Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol Cell Proteomics 2006, 5:2102-2113.
14. Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci U S A 2007, 104:17494-17499.
15. Babel I, Barderas R, Diaz-Uriarte R, Martinez-Torrecuadrada JL, Sanchez-Carbayo M, Casal JI. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 2009, 8:2382-2395.
16. Papp K, Vegh P, Miklos K, Nemeth J, Rasky K, Peterfy F, Erdei A, Prechl J. Detection of complement activation on antigen microarrays generates functional antibody profiles and helps characterization of disease-associated changes of the antibody repertoire. J Immunol 2008, 181:8162-8169.
17. Bacarese-Hamilton T, Gray J, Ardizzoni A, Crisanti A. Allergen microarrays. Methods Mol Med 2005, 114:195-207.
18. Harwanegg C, Hiller R. Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development. Eur Ann Allergy Clin Immunol 2006, 38:232-236.
19. Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, et al. Antigen microarrays identify unique serum autoantibody signatures in clinical andpathologic subtypes of multiple sclerosis. Proc Natl Acad Sci USA 2008, 105:18889-18894.
20. Krenn V, Petersen I, Haupl T, Koepenik A, Blind C, Dietel M, Konthur Z, Skriner K. Array technology and proteomics in autoimmune diseases. Pathol Res Pract 2004, 200:95-103.
21. Bacarese-Hamilton T, Ardizzoni A, Gray J, Crisanti A. Protein Arrays for Serodiagnosis of Disease. Methods in Molecular Biology. Vol. 264, New Jersey: Clifton; 2004, 271-283.
22. Wagner PD,Maruvada P, Srivastava S. Molecular diagnostics: a new frontier in cancer prevention. Expert Rev Mol Diagn 2004, 4:503-511.
23. Garcia BH, 2nd, Hargrave A, Morgan A, Kilmer G, Hommema E, Nahrahari J,Webb B,Wiese R. Antibody microarray analysis of inflammatory mediator release by human leukemia T-cells and human non small cell lung cancer cells. J Biomol Tech 2007, 18:245-251.
24. Belov L,Huang P, Chrisp JS,Mulligan SP, Christopherson RI. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells. J Immunol Methods 2005, 305:10-19.
25. VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, et al. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type. Mol Cell Proteomics 2008, 7:1902-1924.
26. Wulfkuhle JD, Speer R, Pierobon M, Laird J, Espina V, Deng J, Mammano E, Yang SX, Swain SM, Nitti D, et al. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 2008, 7:1508-1517.
27. Cowherd SM, Espina VA, Petricoin EF III, Liotta LA. Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays. Clin Breast Cancer 2004, 5:385-392.
28. Charboneau L, Tory H, Chen T, Winters M, Petricoin EF, 3rd, Liotta LA, Paweletz CP. Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays. Brief Funct Genomic Proteomic 2002, 1:305-315.
29. Wulfkuhle JD, Aquino JA, Calvert VS, Fishman DA, Coukos G, Liotta LA, Petricoin EF, 3rd. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase proteinmicroarrays. Proteomics 2003, 3:2085-2090.
30. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin IE, Liotta LA. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20:1981-1989.
31. Spisak S, Guttman A. Biomedical applications of protein microarrays. Curr Med Chem 2009, 16:2806-2815.
32. Korf U, Henjes F, Schmidt C, Tresch A, Mannsperger H, Lobke C, Beissbarth T, Poustka A. Antibody microarrays as an experimental platform for the analysis of signal transduction networks. Adv Biochem Eng/Biotechnol 2008, 110:153-175.
33. Borrebaeck CA, Wingren C. High-throughput proteomics using antibody microarrays: an update. Expert Rev Mol Diagn 2007, 7:673-686.
34. Walsh CT. Posttranslational Modification of Proteins: Expanding Nature's Inventory. Greenwood Village, CO: Roberts and Company Publishers; 2006.
35. Meri S, Baumann M. Proteomics: posttranslational modifications, immune responses and current analytical tools. Biomol Eng 2001, 18:213-220.
36. Zhu H, Klemic JF, Chang S, Bertone P, Casamayor A, Klemic KG, Smith D, Gerstein M, Reed MA, Snyder M. Analysis of yeast protein kinases using protein chips. Nat Genet 2000, 26:283-289.
37. Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, Fasolo J, Guo H, Jona G, Breitkreutz A, Sopko R, et al. Global analysis of protein phosphorylation in yeast. Nature 2005, 438:679-684.
38. Ptacek J, Snyder M. Charging it up: global analysis of protein phosphorylation. Trends Genet 2006, 22:545-554.
39. Mok J, Im H, Snyder M. Global identification of protein kinase substrates by protein microarray analysis. Nat Protoc 2009, 4:1820-1827.
40. Ekins RP. Ligand assays: from electrophoresis to miniaturized microarrays. Clin Chem 1998, 44:2015-2030.
41. Bradner JE, McPherson OM, Mazitschek R, Barnes-Seeman D, Shen JP, Dhaliwal J, Stevenson KE, Duffner JL, Park SB, Neuberg DS, et al. A robust small-molecule microarray platform for screening cell lysates. Chem Biol 2006, 13:493-504.
42. Zhu H, Snyder M. Protein arrays andmicroarrays. Curr Opin Chem Biol 2001, 5:40-45.
43. Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, Lan N, Jansen R, Bidlingmaier S, Houfek T, et al. Global analysis of protein activities using proteome chips. Science 2001, 293:2101-2105.
44. Schweitzer B, Predki P, Snyder M. Microarrays to characterize protein interactions on a whole-proteome scale. Proteomics 2003, 3:2190-2199.
45. Jona G, Snyder M. Recent developments in analytical and functional protein microarrays. Curr Opin Mol Ther 2003, 5:271-277.
46. Haab BB, Zhou H. Multiplexed protein analysis using spotted antibody microarrays. Methods Mol Biol 2004, 264:33-45.
47. Haab BB, Dunham MJ, Brown PO. Proteinmicroarrays for highly parallel detection and quantitation of specificproteins and antibodies in complex solutions. Genome Biol 2001, 2:RESEARCH0004.
48. Haab BB. Multiplexed protein analysis using antibody microarrays and label-based detection. Methods Mol Med 2005, 114:183-194.
49. Haab BB. Methods and applications of antibody microarrays in cancer research. Proteomics 2003, 3:2116-2122.
50. Haab BB. Advances in protein microarray technology for protein expression and interaction profiling. Curr Opin Drug Discov Devel 2001, 4:116-123.
51. Uttamchandani M, Chen GY, Lesaicherre ML, Yao SQ. Site-specific peptide immobilization strategies for the rapid detection of kinase activity onmicroarrays. Methods Mol Biol 2004, 264:191-204.
52. Lesaicherre ML, Uttamchandani M, Chen GY, Yao SQ. Antibody-based fluorescence detection of kinase activity on a peptide array. Bioorg Med Chem Lett 2002, 12:2085-2088.
53. Nielsen UB, Cardone MH, Sinskey AJ, MacBeath G, Sorger PK. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci U S A 2003, 100:9330-9335.
54. Wang D. Carbohydrate microarrays. Proteomics 2003, 3:2167-2175.
55. Ratner DM, Adams EW, Su J,O'Keefe BR, Mrksich M, Seeberger PH. Probing protein-carbohydrate interactions with microarrays of synthetic oligosaccharides. Chembiochem 2004, 5:379-382.
56. Park S, Lee MR, Pyo SJ, Shin I. Carbohydrate chips for studying high-throughput carbohydrate-protein interactions. J Am Chem Soc 2004, 126:4812-4819.
57. Hirabayashi J. Oligosaccharide microarrays for glycomics. Trends Biotechnol 2003, 21:141-143. Discussion 143.
58. Fukui S, Feizi T, Galustian C, Lawson AM, Chai W. Oligosaccharidemicroarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat Biotechnol 2002, 20:1011-1017.
59. Bryan MC, Lee LV, Wong CH. High-throughput identification of fucosyltransferase inhibitors using carbohydrate microarrays. Bioorg Med Chem Lett 2004, 14:3185-3188.
60. Katrlik J, Svitel J, Gemeiner P, Kozar T, Tkac J. Glycan and lectin microarrays for glycomics and medicinal applications. Med Res Rev 2010, 30:394-418.
61. Patwa T, Li C, Simeone DM, Lubman DM. Glycoprotein analysis using protein microarrays and mass spectrometry. Mass Spectrom Rev 2010, 29:830-844.
62. Yue T, Haab BB. Microarrays in glycoproteomics research. Clin Lab Med 2009, 29:15-29.
63. Chen S, Haab BB. Analysis of Glycans on Serum Proteins Using Antibody Microarrays. Methods in Molecular Biology. Vol. 520, New ersey: Clifton; 2009, 39-58.
64. Williamson A, Jin L, Rape M. Preparation of synchronized human cell extracts to study ubiquitination and degradation. Methods Mol Biol 2009, 545:301-312.
65. Merbl Y, Kirschner MW. Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays. Proc Natl Acad Sci U S A 2009, 106:2543-2548.
66. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A 2000, 97:9902-9906.
67. Lim KL, Dawson VL, Dawson TM. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases? Neurobiol Aging 2006, 27:524-529.
68. Olzmann JA, Li L, Chin LS. Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem 2008, 15:47-60.
69. O'Brien PM, Davies MJ, Scurry JP, Smith AN, Barton CA, Henderson MJ, Saunders DN, Gloss BS, Patterson KI, Clancy JL, et al. The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Br J Cancer 2008, 98:1085-1093.
70. Nyhan MJ, O'Sullivan GC, McKenna SL. Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor. Biochem Soc Trans 2008, 36:472-478.
71. Melino G, Gallagher E, Aqeilan RI, Knight R, Peschiaroli A, Rossi M, Scialpi F, Malatesta M, Zocchi L, Browne G, et al. Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death Differ 2008, 15:1103-1112.
72. Jansen MP, Ruigrok-Ritstier K, Dorssers LC, van Staveren IL, Look MP, Meijer-van Gelder ME, Sieuwerts AM, Helleman J, Sleijfer S, Klijn JG, et al. Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer. Breast Cancer Res Treat 2009, 116:263-271.
73. Fujita T, Liu W, Doihara H, Date H, Wan Y. Dissection of the APCCdh1-Skp2 cascade in breast cancer. Clin Cancer Res 2008, 14:1966-1975.
74. He M, Stoevesandt O, Taussig MJ. In situ synthesis of protein arrays. Curr Opin Biotechnol 2008, 19:4-9.
75. Sorger PK. A reductionist's systems biology: opinion. Curr Opin Cell Biol 2005, 17:9-11.